News
Genetic Analysis AS publishes year-end report 2024
OSLO, NORWAY – 26 February 2025: Genetic Analysis AS (the “Company”, Ticker: GEAN) hereby publishes the year-end report for the…
Genetic Analysis and Ferring Pharmaceuticals Announce A Collaboration To Develop A New Microbiome Rapid Diagnostic Test
Oslo, Norway – 20 December, 2024 – Ferring Pharmaceuticals and microbiome diagnostics specialists Genetic Analysis will bring together two established…
Genetic Analysis AS: Mandatory notification of trade – Primary Insiders
OSLO, NORWAY – 25 November 2024: Genetic Analysis AS (“GA” or “the Company”) announces that members of the management has…
Publication of Q3 Interim Report January – September 2024
OSLO, NORWAY – 15 November 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) hereby publishes the third…
Publication of Half-year report 2024
OSLO, NORWAY – 30 August 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) hereby publishes the interim…
Genetic Analysis AS launches the GA-map® Discovery reagent kit – a precision microbiome research assay
OSLO, NORWAY – 15 August 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces the launch of…
Genetic Analysis launches consumer microbiome testing platform through Prokarimi, powered by GA-map® technology
OSLO, NORWAY – August 8, 2024: Microbiome DX company Genetic Analysis AS (“GA”) announces the completion and launch of a…
Minutes from the Extraordinary General Meeting 17 July 2024 in Genetic Analysis AS
Oslo, Norway, July 17, 2024 – Genetic Analysis AS (the “Company”, Ticker: GEAN) held an Extraordinary General Meeting today, July…
Genetic Analysis: Direct issue has now been registered with the Norwegian Register of Business Enterprises
OSLO, NORWAY – July 15, 2024: Microbiome DX company Genetic Analysis AS (“GA” or the “Company”) hereby announces that the…
Genetic Analysis AS: Mandatory notification of trade – Primary Insider
OSLO, NORWAY – 04 July 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the management…
Notice of Extraordinary General Meeting 2024
Oslo, Norway, July 3, 2024 – Notice is hereby served that an extraordinary general meeting of Genetic Analysis AS (the…
Genetic Analysis: Flagging notification
OSLO, NORWAY – July 1, 2024: Microbiome DX company Genetic Analysis AS (“GA” or the “Company”) hereby announces that an…
Genetic Analysis announces placement of a directed share issue of approximately NOK 4.97 million
Genetic Analysis AS (“GA” or the “Company”) is pleased to announce that it has successfully placed a directed issue and…
Genetic Analysis: Awarded important EU patent covering a companion diagnostic method for optimising IBS interventions
OSLO, NORWAY – 13 June 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces today the grant…
Genetic Analysis AS: CFO resigns to pursue other opportunities
OSLO, NORWAY – 06 June 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that Eilert Aamodt…